EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral Active Carbon Quantum Dots for Diabetes

Gamze Camlik, Besa Bilakaya iD, Esra Küpeli Akkol iD, Adrian Joshua Velaro iD, Siddhanshu Wasnik iD, Adi Muradi Muhar, Ismail Tuncer Degim iD, Eduardo Sobarzo-Sánchez iD

Pharmaceuticals · 19.10.2024 · 17 (10) · 1395

DOI: 10.3390/ph17101395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.10.2024. Verfasst von Gamze Camlik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, Biruni University, Istanbul 34015, Türkiye. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Metformin (Met), an oral drug used to treat type II diabetes, is known to control blood glucose levels. Metformin carbon quantum dots (MetCQDs) were prepared to enhance the bioavailability and effectiveness of metformin. Several studies have shown that carbon quantum dots (CQDs) have attractive properties like small particle size, high penetrability, low cytotoxicity, and ease of synthesis. CQDs are made from a carbon source, namely, citric acid, and a heteroatom, such as nitrogen. The active molecule can be a carbon source or a heteroatom, as reported here.

Methods

This study aims to produce MetCQDs from an active molecule. MetCQDs were successfully produced by microwave-based production methods and characterized. The effect of the MetCQDs was tested in Wistar albino rats following a Streptozocin-induced diabetic model.

Results

The results show that the products have a particle size of 9.02 ± 0.04 nm, a zeta potential of −10.4 ± 0.214 mV, and a quantum yield of 15.1 ± 0.045%. Stability studies and spectrophotometric analyses were carried out and the effectiveness of MetCQDs evaluated in diabetic rats. The results show a significant reduction in blood sugar levels (34.1–51.1%) compared to the group receiving only metformin (37.1–55.3%) over a period of 30 to 360 min. Histopathological examinations of the liver tissue indicate improvement in the liver health indicators of the group treated with MetCQDs.

Conclusions

Based on these results, the products have potential therapeutic advantages in diabetes management through their increased efficacy and may have reduced side effects compared to the control group.

Schlagwörter

Stichwörter der Autor:innen

carbon quantum dotsmetforminnanotechnologyoral administrationtype II diabetes

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Biruni University, Istanbul 34015, Türkiye.
  • Biruni University Research Center (B@MER), Biruni University, Istanbul 34015, Türkiye.
  • Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara 06330, Türkiye.
  • Department of Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia.
  • Artisan Karya Abadi Research, Medan 20155, Indonesia.
  • Department of Surgery, Dr. Djasamen Saragih Regional Public Hospital, Pematang Siantar 21121, Indonesia.

ORCID-Profile: Besa Bilakaya, Esra Küpeli Akkol, Adrian Joshua Velaro, Siddhanshu Wasnik, Ismail Tuncer Degim, Eduardo Sobarzo-Sánchez

Zitieren

APA

Camlik, G., Bilakaya, B., Küpeli Akkol, E., Velaro, A. J., Wasnik, S., Muhar, A. M., Degim, I. T., & Sobarzo-Sánchez, E. (2024). Oral Active Carbon Quantum Dots for Diabetes. Pharmaceuticals, 17(10), 1395. https://doi.org/10.3390/ph17101395

Vancouver

Camlik G, Bilakaya B, Küpeli Akkol E, Velaro AJ, Wasnik S, Muhar AM, et al. Oral Active Carbon Quantum Dots for Diabetes. Pharmaceuticals. 2024;17(10):1395. doi:10.3390/ph17101395

BibTeX
@article{Camlik2024,
  author = {Camlik, Gamze and Bilakaya, Besa and Küpeli Akkol, Esra and Velaro, Adrian Joshua and Wasnik, Siddhanshu and Muhar, Adi Muradi and Degim, Ismail Tuncer and Sobarzo-Sánchez, Eduardo},
  title = {Oral Active Carbon Quantum Dots for Diabetes},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {10},
  pages = {1395},
  doi = {10.3390/ph17101395}
}
Kostenlos starten →